U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07737158) titled 'Venlafaxine for Non-specific Low Back Pain' on July 27.
Brief Summary: Chronic non-specific low back pain is the leading cause of productivity loss and disability worldwide, constituting a major public health challenge. This study aims to systematically evaluate and compare the role of the antidepressant drug Venlafaxine in chronic non-specific low back pain, which is of critical importance for optimising clinical practice and developing precise, individualised treatment regimens.
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condition:
Non-specific Low Back Pain
Pain Management
Intervention:
DRUG: Control Group
Parti...